We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
-12.28%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$334B
AUM Growth
-$65.4B
Cap. Flow
-$11.7B
Cap. Flow %
-3.51%
Top 10 Hldgs %
13.97%
Holding
7,016
New
146
Increased
2,663
Reduced
3,412
Closed
209

Sector Composition

Rank Sector Weight
1 Technology 12.53%
2 Healthcare 10.36%
3 Financials 9.14%
4 Consumer Discretionary 7.65%
5 Communication Services 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TPST icon
6201
Tempest Therapeutics
TPST
$13.8M
$3K ﹤0.01%
2
YCBD icon
6202
cbdMD
YCBD
$5.25M
$3K ﹤0.01%
+3
New +$4.27K
YLDE icon
6203
ClearBridge Dividend Strategy ESG ETF
YLDE
$169M
$3K ﹤0.01%
+100
New +$2.77K
RDGT
6204
Ridgetech Inc
RDGT
$2.79M
0
AUMN
6205
DELISTED
Golden Minerals Company
AUMN
$3K ﹤0.01%
469
-120
-20% -$696
MOTS
6206
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$3K ﹤0.01%
+4
New +$4.45K
BIOC
6207
DELISTED
Biocept, Inc.
BIOC
$3K ﹤0.01%
+13
New +$6.53K
VYNT
6208
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$3K ﹤0.01%
92
-32
-26% -$2.7K
IRCP
6209
DELISTED
IRSA Propiedades Comerciales S.A.
IRCP
$3K ﹤0.01%
+709
New +$3.61K
IEC
6210
DELISTED
IEC Electronics Corp.
IEC
$3K ﹤0.01%
521
GMO
6211
DELISTED
General Moly, Inc.
GMO
$3K ﹤0.01%
15,000
DLBS
6212
DELISTED
iPath US Treasury Long Bond Bear ETN
DLBS
$3K ﹤0.01%
150
SDT
6213
DELISTED
SANDRIDGE MISSISSIPPIAN TRUST I
SDT
$3K ﹤0.01%
3,800
-12,734
-77% -$13.7K
NVLN
6214
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$3K ﹤0.01%
2,839
-1,627,631
-100% -$1.84M
HMTA
6215
DELISTED
HomeTown Bankshares Corporation Common Stock
HMTA
$3K ﹤0.01%
228
-274
-55% -$3.88K
HPJ
6216
DELISTED
Highpower International Inc
HPJ
$3K ﹤0.01%
1,341
FLRU
6217
DELISTED
Franklin FTSE Russia ETF
FLRU
$3K ﹤0.01%
+134
New +$3K
MTL.PR
6218
DELISTED
Mechel PAO American Depositary Shares (each representing one-half of a Preferred Share)
MTL.PR
$3K ﹤0.01%
4,000
IIJI
6219
DELISTED
Internet Initiative Japan Inc
IIJI
$3K ﹤0.01%
250
PGLC
6220
DELISTED
Pershing Gold Corporation. Common Stock
PGLC
$3K ﹤0.01%
3,028
+196
+7% +$234
AHCO icon
6221
AdaptHealth
AHCO
$1.45B
$2K ﹤0.01%
200
-800
-80% -$7.84K
BLNK icon
6222
Blink Charging
BLNK
$76.6M
$2K ﹤0.01%
1,010
-6
-0.6% -$13
BNGO icon
6223
Bionano Genomics
BNGO
$11.7M
$2K ﹤0.01%
1
DSS icon
6224
DSS Inc
DSS
$4.97M
$2K ﹤0.01%
5
+1
+25% +$535
ETON icon
6225
Eton Pharmaceutcials
ETON
$1.27B
$2K ﹤0.01%
+400
New +$2.45K

Similar funds

Morgan Stanley's Q4 2018 Portfolio in Review

As of Q4 2018, Morgan Stanley held 7,016 positions worth $334B, down 16% from $400B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Morgan Stanley withdrew a net $11.7B in Q4 2018, closing 209 positions and reducing 3,412 holdings. Its most notable exit was Praxair Inc, an estimated $398M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Morgan Stanley opened a new position in Linde worth $342M.

  • Morgan Stanley's largest Q4 2018 buy was Linde: 2,188,871 shares worth $342M.
  • Morgan Stanley added most to People Inc in Q4 2018, an estimated $558M increase.
  • Morgan Stanley's biggest Q4 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
  • Morgan Stanley fully exited Praxair Inc in Q4 2018, selling an estimated $398M.
  • Morgan Stanley's ten largest holdings make up 14% of its $334B portfolio in Q4 2018.
  • Morgan Stanley opened 146 new positions and closed 209 in Q4 2018.
  • Morgan Stanley's portfolio value fell 16% quarter-over-quarter to $334B.

Based on Morgan Stanley's 13F filing for Q4 2018, filed 14 Feb 2019.